ArticleBioengineering (Basel, Switzerland)2024
Interactive Cascaded Network for Prostate Cancer Segmentation from Multimodality MRI with Automated Quality Assessment.
Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cascaded Deep Learning-Based Model for Classification and Segmentation of Plaques from Carotid Ultrasound Images.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The accurate segmentation of prostate cancer (PCa) from multiparametric MRI is crucial in clinical practice for guiding biopsy and treatment planning. Existing automated methods often lack the necessary accuracy and robustness in localizing PCa, whereas interactive segmentation methods, although more accurate, require user intervention on each input image, thereby limiting the cost-effectiveness of the segmentation workflow. Our innovative framework addresses the limitations of current methods by combining a coarse segmentation network, a rejection network, and an interactive deep network known as Segment Anything Model (SAM). The coarse segmentation network automatically generates initial segmentation results, which are evaluated by the rejection network to estimate their quality. Low-quality results are flagged for user interaction, with the user providing a region of interest (ROI) enclosing the lesions, whereas for high-quality results, ROIs were cropped from the automatic segmentation. Both manually and automatically defined ROIs are fed into SAM to produce the final fine segmentation. This approach significantly reduces the annotation burden and achieves substantial improvements by flagging approximately 20% of the images with the lowest quality scores for manual annotation. With only half of the images manually annotated, the final segmentation accuracy is statistically indistinguishable from that achieved using full manual annotation. Although this paper focuses on prostate lesion segmentation from multimodality MRI, the framework can be adapted to other medical image segmentation applications to improve segmentation efficiency while maintaining high accuracy standards.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.